Human Dermal Fibroblast - Juvenile
CAD$490.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | Human dermal fibroblasts derived from juvenile donors represent primary mesenchymal cells isolated from the dermis of young individuals. These cells exhibit the characteristic spindle-shaped morphology and robust proliferative capacity typical of fibroblasts, with generally higher growth rates and longer replicative lifespans compared to adult-derived counterparts. Juvenile dermal fibroblasts actively synthesize and remodel extracellular matrix components, including type I and III collagen, fibronectin, and proteoglycans, reflecting their critical role in skin development, structural maintenance, and wound repair. Juvenile fibroblasts are often characterized by lower levels of senescence-associated markers and reduced baseline expression of inflammatory mediators, making them particularly suitable for studies focused on tissue regeneration, fibrosis, and developmental biology. Their responsiveness to mechanical and biochemical cues also makes them a valuable in vitro model for investigating dermal remodeling and cell–matrix interactions. Human juvenile dermal fibroblasts are widely used in research areas including wound healing, regenerative medicine, and cosmetic science. Due to their high proliferative potential and active extracellular matrix production, they serve as an effective model for evaluating biomaterials, drug responses, and anti-aging strategies. However, as primary cells, they retain donor-dependent variability and have a finite lifespan in culture, necessitating careful experimental design and early passage use for reproducible results. |
|---|---|
| Organism | Human |
| Tissue | Skin |
Characteristics
| Age | 1-17 years |
|---|---|
| Gender | Sex unspecified |
| Morphology | Bipolar, refractile and spindle-Âshaped |
| Cell type | Skin fibroblast |
| Growth properties | Adherent |
Regulatory Data
| Citation | Juvenile Human Dermal Fibroblasts (Cytion catalog number 300691) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
Biomolecular Data
Handling
| Culture Medium | CTIGM.Fibro : Growth Medium for Fibroblasts |
|---|---|
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300691-SK1138 | Certificate of Analysis | 30. Mar. 2026 | 300691 |
| 300691-SK0863 | Certificate of Analysis | 30. Mar. 2026 | 300691 |
| 300691-SK1124 | Certificate of Analysis | 30. Mar. 2026 | 300691 |